188 related articles for article (PubMed ID: 34844768)
21. Design, synthesis and bioactivity study of evodiamine derivatives as multifunctional agents for the treatment of hepatocellular carcinoma.
Fan X; Deng J; Shi T; Wen H; Li J; Liang Z; Lei F; Liu D; Zhang H; Liang Y; Hao X; Wang Z
Bioorg Chem; 2021 Sep; 114():105154. PubMed ID: 34378540
[TBL] [Abstract][Full Text] [Related]
22. A novel multitarget kinase inhibitor BZG with potent anticancer activity in vitro and vivo enhances efficacy of sorafenib through PI3K pathways in hepatocellular carcinoma cells.
Wang L; Zhan Y; Wu Z; Lin M; Jin X; Jiang L; Qiu Y
Biomed Pharmacother; 2020 May; 125():110033. PubMed ID: 32187962
[TBL] [Abstract][Full Text] [Related]
23. Longikaurin A, a natural ent-kaurane, induces G2/M phase arrest via downregulation of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in hepatocellular carcinoma cells.
Liao YJ; Bai HY; Li ZH; Zou J; Chen JW; Zheng F; Zhang JX; Mai SJ; Zeng MS; Sun HD; Pu JX; Xie D
Cell Death Dis; 2014 Mar; 5(3):e1137. PubMed ID: 24651440
[TBL] [Abstract][Full Text] [Related]
24. Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway.
Zhao S; Xu K; Jiang R; Li DY; Guo XX; Zhou P; Tang JF; Li LS; Zeng D; Hu L; Ran JH; Li J; Chen DL
Life Sci; 2020 Jun; 251():117424. PubMed ID: 32057900
[TBL] [Abstract][Full Text] [Related]
25. Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of
Liang Y; Xie Y; Liu X; Yu L; Yan H; Shang Z; Wu Y; Cai X; Shi W; Du J; Yang Z
Drug Des Devel Ther; 2024; 18():2169-2187. PubMed ID: 38882048
[TBL] [Abstract][Full Text] [Related]
26. Volatile oil from Saussurea lappa exerts antitumor efficacy by inhibiting epithelial growth factor receptor tyrosine kinase-mediated signaling pathway in hepatocellular carcinoma.
Lin X; Peng Z; Fu X; Liu C; Xu Y; Ji W; Fan J; Chen L; Fang L; Huang Y; Su C
Oncotarget; 2016 Nov; 7(48):79761-79773. PubMed ID: 27806329
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells.
Sbenati RM; Zaraei SO; El-Gamal MI; Anbar HS; Tarazi H; Zoghbor MM; Mohamood NA; Khakpour MM; Zaher DM; Omar HA; Alach NN; Shehata MK; El-Gamal R
Eur J Med Chem; 2021 Jan; 210():113081. PubMed ID: 33310290
[TBL] [Abstract][Full Text] [Related]
28. Mistletoe extract Fraxini inhibits the proliferation of liver cancer by down-regulating c-Myc expression.
Yang P; Jiang Y; Pan Y; Ding X; Rhea P; Ding J; Hawke DH; Felsher D; Narla G; Lu Z; Lee RT
Sci Rep; 2019 Apr; 9(1):6428. PubMed ID: 31015523
[TBL] [Abstract][Full Text] [Related]
29. Neochamaejasmin A extracted from Stellera chamaejasme L. induces apoptosis involving mitochondrial dysfunction and oxidative stress in Sf9 cells.
Ren Y; Mu Y; Yue Y; Jin H; Tao K; Hou T
Pestic Biochem Physiol; 2019 Jun; 157():169-177. PubMed ID: 31153465
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effects of β,β-dimethylacrylshikonin on hepatocellular carcinoma in vitro and in vivo.
Wu YY; Wan LH; Zheng XW; Shao ZJ; Chen J; Chen XJ; Liu LT; Kuang WJ; Tan XS; Zhou LM
Phytother Res; 2012 May; 26(5):764-71. PubMed ID: 22109831
[TBL] [Abstract][Full Text] [Related]
31. Herbal extract "Songyou Yin" inhibits tumor growth and prolongs survival in nude mice bearing human hepatocellular carcinoma xenograft with high metastatic potential.
Huang XY; Wang L; Huang ZL; Zheng Q; Li QS; Tang ZY
J Cancer Res Clin Oncol; 2009 Sep; 135(9):1245-55. PubMed ID: 19277711
[TBL] [Abstract][Full Text] [Related]
32. MEK inhibition by cobimetinib suppresses hepatocellular carcinoma and angiogenesis in vitro and in vivo.
Tong X; Wang Q; Wu D; Bao L; Yin T; Chen H
Biochem Biophys Res Commun; 2020 Feb; 523(1):147-152. PubMed ID: 31836141
[TBL] [Abstract][Full Text] [Related]
33. The Effect of p53-R249S on the Suppression of Hepatocellular Carcinoma Cells Survival Induced by Podophyllum Derivatives.
Chen H; Zhang M; Wang Z; Li L; Li Q; Wang H
Anticancer Agents Med Chem; 2020; 20(7):865-874. PubMed ID: 32067620
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of mitochondrial respiration overcomes hepatocellular carcinoma chemoresistance.
Sun Y; Xu H; Chen X; Li X; Luo B
Biochem Biophys Res Commun; 2019 Jan; 508(2):626-632. PubMed ID: 30522865
[TBL] [Abstract][Full Text] [Related]
35. Extract of Stellerachamaejasme L(ESC) inhibits growth and metastasis of human hepatocellular carcinoma via regulating microRNA expression.
Liu X; Wang S; Xu J; Kou B; Chen D; Wang Y; Zhu X
BMC Complement Altern Med; 2018 Mar; 18(1):99. PubMed ID: 29554896
[TBL] [Abstract][Full Text] [Related]
36. Artemisia capillaris extract AC68 induces apoptosis of hepatocellular carcinoma by blocking the PI3K/AKT pathway.
Yan H; Jung KH; Kim J; Rumman M; Oh MS; Hong SS
Biomed Pharmacother; 2018 Feb; 98():134-141. PubMed ID: 29253760
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive anti-tumor effect of Brusatol through inhibition of cell viability and promotion of apoptosis caused by autophagy via the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.
Ye R; Dai N; He Q; Guo P; Xiang Y; Zhang Q; Hong Z; Zhang Q
Biomed Pharmacother; 2018 Sep; 105():962-973. PubMed ID: 30021391
[TBL] [Abstract][Full Text] [Related]
38. Activation of the HGF/c-MET axis promotes lenvatinib resistance in hepatocellular carcinoma cells with high c-MET expression.
Fu R; Jiang S; Li J; Chen H; Zhang X
Med Oncol; 2020 Mar; 37(4):24. PubMed ID: 32166604
[TBL] [Abstract][Full Text] [Related]
39. Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells.
Han P; Li H; Jiang X; Zhai B; Tan G; Zhao D; Qiao H; Liu B; Jiang H; Sun X
Mol Oncol; 2017 Mar; 11(3):320-334. PubMed ID: 28164434
[TBL] [Abstract][Full Text] [Related]
40. Anticancer effects of Poncirus fructus on hepatocellular carcinoma through regulation of apoptosis, migration, and invasion.
Munakarmi S; Chand L; Shin HB; Hussein UK; Yun BS; Park HR; Jeong YJ
Oncol Rep; 2020 Dec; 44(6):2537-2546. PubMed ID: 33125135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
